Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
Given the importance of inflammation at the onset of multiple sclerosis (MS), therapy is mainly based on the use of anti-inflammatory drugs including disease modifying therapies (DMTs). Considering the recent approval of some DMTs, pharmacovigilance becomes a fundamental tool for the acquisition of...
Príomhchruthaitheoirí: | , , , , , , |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Frontiers Media S.A.
2022-02-01
|
Sraith: | Frontiers in Pharmacology |
Ábhair: | |
Rochtain ar líne: | https://www.frontiersin.org/articles/10.3389/fphar.2022.808370/full |